Clinical validation of artificial intelligence (AI) solutions for treatment and care

This section outlines the eligibility criteria for participation in the program, specifying the types of entities that can apply, the geographical scope of the funded activities, and the overarching objectives aimed at improving health outcomes and healthcare systems.

This section details the thematic focus of the program, outlining the specific areas of research and innovation it supports, the types of costs eligible for funding, and the typical development stage of projects. The program exclusively targets non-communicable diseases.

This section provides an overview of the financial support offered, including the type of financial instrument, the indicative funding amounts per project, and general aspects of project duration.

This section outlines the essential conditions and requirements that applicants and beneficiaries must adhere to throughout the application and project implementation phases. It covers administrative stipulations, collaboration rules, and ethical considerations.

This section guides potential applicants through the process of submitting their proposals, detailing the procedural steps, relevant documents, and the method by which applications are assessed and awarded.

This section identifies the core legal and policy documents that authorize and govern the "Clinical Validation of Artificial Intelligence (AI) Solutions for Treatment and Care" funding program, providing the foundation for its operational framework.